Stay updated on Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial page.

Latest updates to the Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRecruitment status is updated to show the study is no longer seeking participants. The history also adds a new revision tag (v3.6.0) and removes the older revision (v3.5.5).SummaryDifference0.2%

- Check16 days agoChange DetectedRevision tag on the page updated from v3.5.4 to v3.5.5, indicating a new build of the ClinicalTrials.gov history page; the underlying study information remains the same.SummaryDifference0.0%

- Check38 days agoChange DetectedThe record history now includes revision v3.5.4 and removes v3.5.3, indicating an update to the page's release history. This change does not alter study content or visible information.SummaryDifference0.0%

- Check52 days agoChange DetectedThe Record History page shows an updated revision label, changing from Revision: v3.5.2 to Revision: v3.5.3, indicating a new build of the history interface.SummaryDifference0.0%

- Check67 days agoChange DetectedIPDSharing and Study Status entries were added in the latest version (61, Revision: v3.5.2). This is a metadata/UI update and does not change the core study information or results.SummaryDifference0.3%

- Check95 days agoChange DetectedAdded revision v3.5.0 to the record history and removed revision v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial page.